Masaru Samura

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 89 citations · Full text

Vaccination, Vaccine Safety, Two-dose Heterologous Ad26.zebov +9

Support for fungal infection treatment mediated by pharmacist-led antifungal stewardship activities

Masaru Samura, Naoki Hirose, Takenori Kurata et al. · Journal of Infection and Chemotherapy · 2019 · 25 citations

Antifungal Agent, Antimicrobial Stewardship, Fungal Pathogen +7

Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease

Masaru Samura, Keisuke Takada, Risako Yamamoto et al. · Pharmaceutical Research · 2021 · 17 citations

Urology, Unbound Daptomycin Concentration, Pharmacokinetic Modeling +10

Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study

Kazutaka Oda, Tomoyuki Yamada, Kazuaki Matsumoto et al. · Clinical and Translational Science · 2023 · 17 citations · Full text

Identification of Risk Factors for Daptomycin-Associated Creatine Phosphokinase Elevation and Development of a Risk Prediction Model for Incidence Probability

Masaru Samura, Naoki Hirose, Takenori Kurata et al. · Open Forum Infectious Diseases · 2021 · 16 citations · Full text